MARSHALL WACE, LLP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,695,000
-26.1%
58,078
-22.1%
0.00%
-70.0%
Q2 2021$2,295,000
-26.1%
74,552
-37.1%
0.01%
-28.6%
Q1 2021$3,105,000
+22.1%
118,609
+17.3%
0.01%0.0%
Q4 2020$2,543,000
-27.0%
101,109
-39.5%
0.01%
-36.4%
Q3 2020$3,483,000
-65.2%
167,137
-60.3%
0.02%
-68.6%
Q2 2020$10,001,000
+97.7%
421,100
+49.8%
0.07%
+37.3%
Q1 2020$5,058,000
-33.3%
281,169
-12.0%
0.05%
-1.9%
Q4 2019$7,582,000
-56.6%
319,663
-49.7%
0.05%
-62.0%
Q3 2019$17,470,000
-5.5%
635,748
+13.8%
0.14%
-9.9%
Q2 2019$18,488,000
-58.3%
558,703
-55.8%
0.15%
-27.3%
Q1 2019$44,342,000
+214.8%
1,265,460
+198.5%
0.21%
+45.1%
Q4 2018$14,085,000
+2661.8%
423,964
+4089.4%
0.14%
+7100.0%
Q3 2018$510,000
+5.4%
10,120
-68.1%
0.00%
-60.0%
Q1 2016$484,000
-79.4%
31,747
-81.8%
0.01%
-77.3%
Q4 2015$2,345,000174,5130.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders